Luna Trading Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Luna Trading Pharmaceutical Import Records from India — 3 Products, $83.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Luna Trading — Pharmaceutical Importer Profile (2026) | 3 Products, $83.8K Trade | TransData Nexus

Luna Trading

Pharmaceutical Importer · Nepal · Ayurvedic & Herbal Products Focus · $83.8K Total Trade · DGFT Verified

Luna Trading is a pharmaceutical importer based in Nepal with a total trade value of $83.8K across 3 products in 1 therapeutic categories. Based on 66 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Luna Trading sources from 1 verified Indian supplier, with Dabur India Limited accounting for 100.0% of imports.

Luna Trading — Import Portfolio & Supplier Network

Luna Trading import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Luna Trading?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Dabur India Limited	$2.6M	2,536	100.0%

Luna Trading sources from 1 verified Indian supplier across 873 distinct formulations. The sourcing is highly concentrated — Dabur India Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Luna Trading Import?

Formulation	Value	Ships
Dashmularishta 450 ML	$246.6K	92
Pudin hara 10 pearis x40 strips	$133.9K	14
Honitus syrup 100ML	$130.8K	27
Honitus syrup 100 ML	$129.0K	36
Honitus syrup 100ML	$82.2K	17
Ashokarishta 450 ML	$55.7K	17
Honitus syrup 100 ML	$55.3K	6
Vr vatchintamani ras gold 10 TAB	$43.3K	11
Dashmularishta 450 ML	$40.8K	9
Dashmularishta 450 ML	$36.9K	6
Dabur lal tail 200ML	$36.1K	12
Rasraj ras gold 10 TAB	$35.2K	13
Dashmularishta 450ML	$30.9K	9
Dashmularishta 450ML	$26.2K	6
Honitus syrup	$25.9K	4

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Arishta	Ayurvedic & Herbal Products	$73.1K	40	5.1%	3
2	Asava	Ayurvedic & Herbal Products	$7.6K	17	1.7%	9
3	Gutika	Ayurvedic & Herbal Products	$3.1K	9	2.5%	10

Luna Trading imports 3 pharmaceutical products across 1 categories into Nepal totaling $83.8K.

Luna Trading — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Luna Trading Co. Pvt. Ltd. is a pharmaceutical importer and buyer based in Chainpur, Nepal. The company specializes in importing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $84,000 USD over 66 shipments, Luna Trading focuses exclusively on Ayurvedic and herbal products, reflecting a strategic emphasis on traditional medicine. The company's portfolio is highly concentrated, with the top three products—Arishta, Asava, and Gutika—accounting for 100% of their imports. This indicates a specialized market approach, catering to a niche segment within Nepal's pharmaceutical distribution network.

2Distribution Network

Luna Trading's distribution network is centered in Chainpur, Nepal, with warehouse facilities located in Lipnimal VDC, Chainpur. The company imports pharmaceutical products from India, suggesting established logistics capabilities for cross-border trade. While specific details about their geographic coverage within Nepal are not publicly available, the focus on Ayurvedic and herbal products indicates a targeted distribution strategy, likely serving regions with higher demand for traditional medicines. The company's import data reflects a consistent supply chain, with 66 shipments recorded over a period of time, indicating stable logistics operations.

3Industry Role

Luna Trading operates as a primary wholesaler in Nepal's pharmaceutical supply chain, specializing in the import and distribution of Ayurvedic and herbal products. By focusing exclusively on finished pharmaceutical formulations from a single supplier, Dabur India Limited, the company positions itself as a dedicated distributor of traditional medicines. This specialization allows Luna Trading to cater to a specific market segment, meeting the demand for Ayurvedic products in Nepal. Their role is pivotal in bridging the supply of Indian-manufactured Ayurvedic medicines to the Nepalese market, ensuring availability and distribution within the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Luna Trading

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Luna Trading's sourcing strategy exhibits a high degree of concentration, relying exclusively on Dabur India Limited for its pharmaceutical imports. This single-source dependency could pose risks, such as supply chain disruptions or price fluctuations. However, the consistent volume of 66 shipments over a period suggests a stable and long-term relationship between Luna Trading and Dabur India Limited. The focus on a single supplier may also reflect strategic choices, such as leveraging established partnerships, ensuring product quality, and maintaining a specialized product portfolio. While this approach offers benefits like streamlined operations and potential cost efficiencies, it also necessitates careful risk management to mitigate potential supply chain vulnerabilities.

2Supply Chain Resilience

Luna Trading's supply chain resilience appears robust, given the consistent import data and exclusive partnership with Dabur India Limited. The company's focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, suggests a streamlined supply chain with fewer complexities. However, the lack of publicly available information on backup suppliers and formulation diversity indicates potential vulnerabilities. The exclusive reliance on a single supplier may expose Luna Trading to risks associated with supply chain disruptions, regulatory changes, or shifts in supplier priorities. To enhance resilience, diversifying the supplier base and incorporating a broader range of formulations could be strategic considerations.

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

The Department of Drug Administration (DDA) is the primary regulatory authority overseeing pharmaceuticals in Nepal. Established in 1979 under the Ministry of Health and Population, the DDA is responsible for regulating the production, marketing, import, export, storage, supply, sale, and distribution of medicines and health technologies. The legal framework governing pharmaceuticals includes the Drug Act 2035 (1978), which provides comprehensive regulations for drug control, professional standards, and public health security. The DDA enforces compliance with these regulations, ensuring the safety, efficacy, and quality of pharmaceutical products in Nepal.

2Import Licensing & GMP

Importing pharmaceutical products into Nepal requires obtaining an import license from the Department of Drug Administration (DDA). The process involves registering the importing company with the Office of Company Registrar (OCR), obtaining a Permanent Account Number (PAN) and Value Added Tax (VAT) registration, and ensuring compliance with storage requirements, including temperature control. A qualified pharmacist must be employed, and each imported medicine must be registered with the DDA. The DDA conducts inspections to verify compliance with Good Manufacturing Practice (GMP) standards, which are mandatory for all pharmaceutical products. Recognized GMP certifications include those from the European Union (EU GMP), World Health Organization (WHO GMP), and Pharmaceutical Inspection Co-operation Scheme (PIC/S). (commonlaw.com.np)

Luna Trading — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Luna Trading's exclusive focus on Ayurvedic and herbal products, such as Arishta, Asava, and Gutika, aligns with the growing demand for traditional medicines in Nepal. This strategic emphasis allows the company to cater to a niche market segment seeking natural and holistic health solutions. The import data indicates a preference for products with established market acceptance and consumer trust. By concentrating on these specific therapeutic areas, Luna Trading can leverage market trends favoring natural remedies and position itself as a leading distributor of Ayurvedic products in Nepal.

2Sourcing Profile

Luna Trading's sourcing strategy is centered on importing finished pharmaceutical formulations from a single supplier, Dabur India Limited. This approach ensures consistency in product quality and streamlines supply chain operations. The focus on Ayurvedic and herbal products reflects a strategic decision to specialize in traditional medicine, catering to a specific consumer base in Nepal. By maintaining a narrow product focus and supplier base, Luna Trading can build strong relationships with its supplier and customers, enhancing brand loyalty and market presence.

3Market Positioning

Seller's Guide — How to Become a Supplier to Luna Trading

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Luna Trading, given the company's exclusive reliance on Dabur India Limited. By meeting the specific quality standards and regulatory requirements of the Nepalese market, new suppliers can position themselves as alternative sources for Luna Trading's product portfolio. Diversifying the supplier base could enhance supply chain resilience and provide Luna Trading with more competitive pricing options. For Indian exporters, establishing partnerships with Luna Trading offers a pathway to enter the Nepalese market, leveraging the company's established distribution network and market knowledge.

2Requirements & Qualifications

Indian exporters seeking to supply Luna Trading and the Nepalese market must ensure compliance with the Department of Drug Administration's (DDA) regulations. This includes obtaining a recommendation letter from the DDA, registering each product with the DDA, and ensuring that products meet Good Manufacturing Practice (GMP) standards recognized by the DDA. Additionally, products must comply with labeling requirements, including the use of the Nepali language and adherence to specific formatting guidelines. Ensuring these qualifications will facilitate smoother market entry and partnership opportunities with importers like Luna Trading.

Frequently Asked Questions — Luna Trading

What products does Luna Trading import from India?

Luna Trading imports 3 pharmaceutical products across 1 categories. Top imports: Arishta ($73.1K), Asava ($7.6K), Gutika ($3.1K).

Who supplies pharmaceuticals to Luna Trading from India?

Luna Trading sources from 1 verified Indian suppliers. The primary supplier is Dabur India Limited (100.0% of imports, $2.6M).

What is Luna Trading's total pharmaceutical import value?

Luna Trading's total pharmaceutical import value from India is $83.8K, based on 66 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Luna Trading focus on?

Luna Trading imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Luna Trading Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.